Roles of gastrointestinal polypeptides in intestinal barrier regulation

Peptides. 2022 May:151:170753. doi: 10.1016/j.peptides.2022.170753. Epub 2022 Jan 31.

Abstract

The intestinal barrier is a dynamic entity that is organized as a multilayer system and includes various intracellular and extracellular elements. The gut barrier functions in a coordinated manner to impede the passage of antigens, toxins, and microbiome components and simultaneously preserves the balanced development of the epithelial barrier and the immune system and the acquisition of tolerance to dietary antigens and intestinal pathogens.Numerous scientific studies have shown a significant association between gut barrier damage and gastrointestinal and extraintestinal diseases such as inflammatory bowel disease, celiac disease and hepatic fibrosis. Various internal and external factors regulate the intestinal barrier. Gastrointestinal peptides originate from enteroendocrine cells in the luminal digestive tract and are critical gut barrier regulators. Recent studies have demonstrated that gastrointestinal peptides have a therapeutic effect on digestive tract diseases, enhancing epithelial barrier activity and restoring the gut barrier. This review demonstrates the roles and mechanisms of gastrointestinal polypeptides, especially somatostatin (SST) and vasoactive intestinal peptide (VIP), in intestinal barrier regulation.

Keywords: Gastrointestinal polypeptides; Intestinal barrier; Somatostatin; Vasoactive intestinal peptide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Enteroendocrine Cells
  • Gastrointestinal Diseases*
  • Humans
  • Inflammatory Bowel Diseases*
  • Intestinal Mucosa
  • Vasoactive Intestinal Peptide

Substances

  • Vasoactive Intestinal Peptide